Yen Faces Renewed Pressure as Iran Tensions and US Rate Outlook Strengthen Dollar BNSF Hikes Grain Train Charges Up to 472 Union Pacific Alleges in Federal Complaint Rush RSI Reports Strong Q1 2026 Revenue NA EPS Beats New Employment Data Shows Maryland Lost Nearly 25000 Federal Jobs in 2025 Amid Workforce Reductions Retirees Weigh Options Target Date Funds vs Annuities for 195M Portfolio Child Therapists Insights on Essential People Skills May Inform Corporate Training Approaches Healthcare and Technology Shares Lead Broad Market Advance Elon Musks Critique of The Boys Finale Highlights Cultural Risk in Streaming Investments Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond US Consumer Spending Under Growing Pressure as Tax Cuts Fade and Fuel Costs Surge AIZ Q1 2026 Earnings Strong EPS Beat Overshadowed by Tepid Market Reaction IIPR Q1 2026 Earnings EPS Misses Estimates Amid Persistent Cannabis Sector Headwinds TIMB Q1 2026 Earnings EPS Misses Estimates as Stock Declines on Weak Profitability GSBC Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline BMO Q1 2026 Earnings Strong EPS Beat Drives Optimism Amid Steady Performance ANDE Q1 2026 Earnings Strong EPS Beat Drives Share Gains Syntec Optics Holdings Warrant OPTXW Rallies Over 5 Key Levels in Focus Dyadic International DYAI Slides Near Support as Selling Pressure Continues AnaptysBio ANAB Edges Lower as Shares Test Key Support Near 54 LXP Industrial Trust LXP Holds Steady Near Midpoint Minor Decline Amid Consolidation CBL International Limited BANL Gains Ground Approaching Resistance at 042 Fifth Third Bancorp FITB Edges Higher as Banking Sector Holds Steady NAMS Q1 2026 Earnings Narrowed Loss Beats Estimates Despite PreRevenue Status Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues Cheetah Mobile CMCM Q4 2025 Earnings Loss Per ADS of 110 Stock Declines 35 INTC Q1 2026 Earnings Earnings Surge on Massive EPS Beat Amidst Revenue Uncertainty ALMS Q1 2026 Earnings EPS Beat Partially Offsets Investor Concerns Novartis Lifts Annual Sales and Profit Forecast Amid Strong Operational Momentum GPUS Q3 2025 Earnings Losses Persist as Hyperscale Data Ramps Up Investment Fortress Biotech Preferred Shares FBIOP Gain 237 as Price Approaches Key Resistance